Data Sciences International

Executive Summary

Data Sciences International (DSI) is a leading provider of advanced telemetry, respiratory, and software solutions for preclinical physiologic monitoring in laboratory animals. Founded in 1980 and headquartered in St. Paul, Minnesota, the company delivers reliable, high-fidelity data to enhance the quality and efficiency of scientific research. DSI's products are essential for pharmaceutical and biotechnology companies conducting preclinical studies, enabling real-time monitoring of vital signs in small and large animals. With a valuation of approximately $23 million, DSI operates as a private entity in the medical devices and digital health sectors. Despite its niche focus, DSI faces challenges from emerging competitors offering integrated digital platforms. However, the company's long-standing reputation and customer loyalty provide a competitive moat. The growing demand for preclinical data in drug development, coupled with increasing regulation on animal welfare, positions DSI for steady growth. Key opportunities include expanding its cloud-based data analytics offerings and targeting emerging Asian markets. While the company does not disclose financials, its estimated valuation suggests modest but stable operations.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation telemetry system with real-time data streaming70% success
• Q4 2026FDA 510(k) clearance for a new implantable respiratory monitoring device60% success
• Q1 2027Strategic partnership with a top-10 pharmaceutical company for software integration50% success